IMMUNOGLOBULIN G4-RELATED DISEASE
Clinical trials for IMMUNOGLOBULIN G4-RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGLOBULIN G4-RELATED DISEASE trials appear
Sign up with your email to follow new studies for IMMUNOGLOBULIN G4-RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to tame mysterious autoimmune disease
Disease control Recruiting nowThis study is testing whether an oral medication called rilzabrutinib can better control IgG4-related disease compared to a placebo. Over 52 weeks, researchers will measure if the drug prevents painful disease flares and reduces the need for steroid medications in 124 adult parti…
Matched conditions: IMMUNOGLOBULIN G4-RELATED DISEASE
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Hospital launches major effort to map the mysteries of rare diseases
Knowledge-focused Recruiting nowThis study aims to create a single, large registry to collect information on many different rare diseases. It will enroll about 380 patients already being treated at the Hospital Italiano de Buenos Aires who have one of the listed rare conditions. The goal is to gather data to be…
Matched conditions: IMMUNOGLOBULIN G4-RELATED DISEASE
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:53 UTC